Status
Conditions
Treatments
About
Main Objective The main objective of the study is to investigate the effectiveness of a mobile phone-based intervention in reducing relapse ate among recent quitters who are attending the smoking cessation program in Jazan.
Besides this, the study will achieve the following objective:
To identify the timing and different factors associated with relapse process among recent quitters during first 6 months of quitting.
Full description
Background:
Smoking remains a major public health problem and an important cause of morbidity and mortality worldwide. Although the effectiveness of behavior support and medical treatment, many of those who quit smoking subsequently relapse to smoke.
Objective:
The primary aim of this study will be to determine the effectiveness of the mobile phone-based intervention to prevent relapse among recent smoking quitters. Also, the study aims to identify the different factors associated with relapse among recent quitters during the first 6 months of quitting.
Design and Methods:
A parallel two-armed Randomized Controlled Trial (RCT) to assess the effectiveness of a mobile phone-based intervention for smoking cessation on achieving long term abstinence, will be conducted among volunteers. Participants will be recruited from those attended smoking cessation program in Southern Alrawdha clinic, Southern Abo Arish clinic, Sabia clinic and Aldhabia clinic.
Primary outcome:
The difference in relapsing rate among recent quitters, which may subsequently contribute in to a reduction in smoking rates.
Trail Implications for public Health:
The result of this study will provide evidence for effectiveness of the mobile phone-based intervention versus standard treatment to reduce smoking relapse rate. If proven, it will be a cost-saving intervention by reducing repeat use of the smoking cessation clinic services and by reducing use of healthcare services for smoking-related illness.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
476 participants in 2 patient groups
Loading...
Central trial contact
Ibtihal Altalhi, MBBS; Abdullah Alsabaani, ASST PROF
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal